Viral Conjunctivitis Treatment Study

Avenova for the Treatment of Viral Conjunctivitis

The objective of this study is to determine the efficacy Avenova® (0.01% hypochlorous acid) in the treatment of viral conjunctivitis. The investigators hypothesize that patients treated with Avenova® will have a quicker resolution of their ocular signs and symptoms of Viral Conjunctivitis compared with artificial tears.

Inclusion Criteria:

• Patients presenting to the Bascom Palmer Eye Institute
• Clinical diagnosis of viral conjunctivitis
• Symptoms less than 1 week duration

Exclusion Criteria:

• history of allergic conjunctivitis
• history of herpetic eye disease
• concurrent diagnosis of bacterial conjunctivitis (based off microbiology plating)
• Immunocompromised / Immunosuppressed patients
• Patients with HIV
• pregnant women
• prisoners
• adults who are unable to provide consent